Gil, I am attaching this to the Parkinson's list as well.
Linda Forrest's Mom
Other Formats:
Prog Cardiovasc Dis 1997 Nov;40(3):265-286
Carnitine and its derivatives in cardiovascular disease.
Arsenian MA
Carnitine and its derivative propionyl-L-carnitine are endogenous
cofactors which enhance carbohydrate metabolism and
reduce the intracellular buildup of toxic metabolites in ischemic
conditions. The carnitines have been, and are being used in a
spectrum of diseases including multiple cardiovascular conditions. These
include angina, acute myocardial infarction,
postmyocardial infarction, congestive heart failure, peripheral vascular
disease, dyslipidemia, and diabetes. Most published data
on carnitine, propionyl-L-carnitine, and other carnitine congeners are
favorable but the clinical trials have been relatively small.
In currently used doses, these substances are virtually devoid of
significant side effects.
Publication Types:
Review
Review, academic
PMID: 9406679, UI: 98068514
